Skip to main content

Advertisement

Log in

Brain MRI imaging markers associated with death in children with central nervous system involvement of hemophagocytic lymphohistiocytosis

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the association of brain MRI and clinical variables with death in children with central nervous system involvement of hemophagocytic lymphohistiocytosis (CNS-HLH).

Methods

Clinical and brain MRI data of children with CNS-HLH from January 2012 to March 2022 were reviewed retrospectively. Patients were divided into the deceased group and the surviving group. The intergroup differences of seven brain MRI variables, twelve clinical variables, and underlying diseases were studied.

Results

One hundred and fourteen patients were included in this study, consisting of 59 who died and 55 who survived. The included clinical variables did not show statistically independent correlation with patients’ deaths. For MRI variables, a multivariate analysis demonstrated restricted diffusion of lesion (OR = 9.64, 95% CI: 3.39–27.43, p < 0.001) and count of affected brain regions (CABR) (OR = 1.24, 95% CI: 1.03–1.49, p = 0.02) were independent risk factors for death. ROC curve showed CABR (AUC = 0.79, 95% CI: 0.70–0.87, p < 0.001) is highly predictive for mortality with an optimal cutoff value of 4.5 (sensitivity 76%, specificity 73%). For HLH subtypes, familial HLH (F-HLH, OR = 9.90, 95% CI: 2.01–48.87, p = 0.005) and immune-compromise-related HLH (IC-HLH, OR = 4.95, 95% CI: 1.40–17.46, p = 0.01) presented statistically stronger association with death than infection-related HLH. F-HLH and IC-HLH preferred to have large lesions, restricted diffusion, and more brain regions involved than other subtypes.

Conclusion

Brain MRI features exhibit independent prediction for mortality in children with CNS-HLH, and HLH subtypes pose effects on patient outcomes and brain MRI findings.

Clinical relevance statement

The number of affected brain regions and diffusion restriction of lesion exhibit significant correlation with mortality in children diagnosed with CNS-hemophagocytic lymphohistiocytosis, and may serve as candidate MRI markers for the prediction of the disorder’s severity.

Key Points

The brain MRI markers, restricted diffusion of lesion and count of affected brain regions, significantly correlated with death.

Familial and immune-compromise-related hemophagocytic lymphohistiocytosis presented statistically stronger association with death than infection-related subtype.

Brain MRI is potential in death-predicting for children with central nervous system involvement of hemophagocytic lymphohistiocytosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

CNS:

Central nervous system

CSF:

Cerebrospinal fluid

DPVL:

Diffuse parenchymal volume loss

DWI:

Diffusion-weighted imaging

HLH:

Hemophagocytic lymphohistiocytosis

F-HLH:

Familial hemophagocytic lymphohistiocytosis

I-HLH:

Infection-related hemophagocytic lymphohistiocytosis

IC-HLH:

Immune-compromise-related hemophagocytic lymphohistiocytosis

MRI:

Magnetic resonance imaging

R-HLH:

Rheumatological hemophagocytic lymphohistiocytosis

SI:

Signal intensity

References

  1. Horne AC, Wickstrom R, Jordan MB et al (2017) How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis? Curr Treat Options in Neurol 19:3

    Article  Google Scholar 

  2. Chuang HC, Lay JD, Hsieh WC, Su IJ (2007) Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci 98:1281–1287

    Article  CAS  PubMed  Google Scholar 

  3. Molleran Lee S, Villanueva J, Sumegi J et al (2004) Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet 41:137–144

    Article  CAS  PubMed  Google Scholar 

  4. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 89:794–800

    Article  CAS  PubMed  Google Scholar 

  5. Deiva K, Mahlaoui N, Beaudonnet F et al (2012) CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis. Neurology 78:1150–1156

    Article  CAS  PubMed  Google Scholar 

  6. Wen FY, Xiao L, Liao ML et al (2018) Clinical features and prognosis of central nervous system involvement in patients with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis. J Chin J Appl Clin Pediatr 33:453–457. https://doi.org/10.3760/cma.j.issn.2095-428X.2018.06.014

    Article  Google Scholar 

  7. Wen FY, Xiao L, Xian Y et al (2017) Prognosis of the central nervous system involvement in patients with hemophagocytic lymphohistiocytosis. Chin J Hematol 38:848–852. https://doi.org/10.3760/cma.j.issn.0253-2727.2017.10.005

    Article  CAS  Google Scholar 

  8. Kim MM, Yum MS, Choi HW et al (2012) Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis. Korean J Hematol 47:273–280

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhao YZ, Zhang Q, Li ZG et al (2018) Central nervous system involvement in 179 Chinese children with hemophagocytic lymphohistiocytosis. Chin Med J (Engl) 131:1786–1792

    Article  PubMed  Google Scholar 

  10. Yang S, Zhang L, Jia C, Ma H, Henter JI, Shen K (2010) Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 54:408–415

    Article  PubMed  Google Scholar 

  11. Ma W, Li XJ, Li W, Xiao L, Ji XJ, Xu Y (2021) MRI findings of central nervous system involvement in children with haemophagocytic lymphohistiocytosis: correlation with clinical biochemical tests. Clin Radiol 76:159.e9-159.e17

    Article  CAS  PubMed  Google Scholar 

  12. Henter JI, Horne A, Aricó M et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124–131

    Article  PubMed  Google Scholar 

  13. China Expert Alliance on Hemophagocytic Syndrome and Hematology Group of the Society of Pediatrics CM Association (2018) Chinese expert consensus on diagnosis and treatment of hemophagocytic syndrome. Chin Med J (cn) 98:91–95. https://doi.org/10.3760/cma.j.issn.0376-2491.2018.02.004

    Article  Google Scholar 

  14. Zecca C, Cereda C, Wetzel S et al (2012) Diffusion-weighted imaging in acute demyelinating myelopathy. Neuroradiology 54:573–578

    Article  PubMed  Google Scholar 

  15. Oren NC, Chang E, Yang CW, Lee SK (2019) Brain diffusion imaging findings may predict clinical outcome after cardiac arrest. J Neuroimaging 29:540–547

    Article  PubMed  Google Scholar 

  16. Jordan MB, Allen CE, Greenberg J et al (2019) Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer 66:e27929

    Article  PubMed  PubMed Central  Google Scholar 

  17. Imashuku S, Hyakuna N, Funabiki T et al (2002) Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis. Cancer 94:3023–3031

    Article  PubMed  Google Scholar 

  18. Parida A, Abdel-Mannan O, Mankad K et al (2022) Isolated central nervous system familial hemophagocytic lymphohistiocytosis (fHLH) presenting as a mimic of demyelination in children. Mult Scler 28:669–675

    Article  CAS  PubMed  Google Scholar 

  19. Chong KW, Lee JH, Choong CT et al (2012) Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvement. J Child Neurol 27:1336–1339

    Article  PubMed  Google Scholar 

  20. Ou W, Zhao Y, Wei A et al (2023) Chronic active Epstein-Barr virus infection with central nervous system involvement in children: a clinical study of 22 cases. Pediatr Infect Dis J 42:20–26

    Article  PubMed  Google Scholar 

  21. Goo HW, Weon YC (2007) A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis. Pediatr Radiol 37:1110–1117

    Article  PubMed  Google Scholar 

  22. Trottestam H, Horne A, Arico M et al (2011) Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 118:4577–4584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Oguz MM, Sahin G, AltinelAcoglu E et al (2019) Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis. Pediatr Hematol Oncol 36:1–16

    Article  PubMed  Google Scholar 

  24. Koh KN, Im HJ, Chung NG et al (2015) Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol 94:51–59

    Article  CAS  PubMed  Google Scholar 

  25. Tang YM, Luo Z (2018) Prognostic factors of early death in children with hemophagocytic lymphohistiocytosis. Cytokine 110:481–482

    Article  CAS  PubMed  Google Scholar 

  26. Huang J, Yin G, Duan L et al (2020) Prognostic value of blood-based inflammatory biomarkers in secondary hemophagocytic ymphohistiocytosis. J Clin Immunol 40:718–728

    Article  CAS  PubMed  Google Scholar 

  27. Song Y, Pei RJ, Wang YN, Zhang J, Wang Z (2018) Central nervous system involvement in hemophagocytic lymphohistiocytosis in adults: a retrospective analysis of 96 patients in a single center. Chin Med J (Engl) 131:776–783

    Article  PubMed  Google Scholar 

  28. Chung TW (2007) CNS involvement in hemophagocytic lymphohistiocytosis: CT and MR findings. Korean J Radiol 8:78–81

    Article  PubMed  PubMed Central  Google Scholar 

  29. Guandalini M, Butler A, Mandelstam S (2014) Spectrum of imaging appearances in Australian children with central nervous system hemophagocytic lymphohistiocytosis. J Clin Neurosci 21:305–310

    Article  PubMed  Google Scholar 

  30. Decaminada N, Cappellini M, Mortilla M et al (2010) Familial hemophagocytic lymphohistiocytosis: clinical and neuroradiological findings and review of the literature. Childs Nerv Syst 26:121–127

    Article  PubMed  Google Scholar 

  31. Faitelson Y, Grunebaum E (2014) Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin Immunol 155:118–125

    Article  CAS  PubMed  Google Scholar 

  32. Marc T, Kevin R (2013) Neurological expression of genetic immunodeficiencies and of opportunistic infections. Handb Clin Neurol 112:1219–1227

    Article  PubMed  Google Scholar 

  33. Canna SW, Marsh RA (2020) Pediatric hemophagocytic lymphohistiocytosis. Blood 135:1332–1343

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received funding from the National Natural Science Foundation of China (81301300), Chongqing Science and Technology Foundation, and Chongqing Science and Technology Commission (cstc2018jscx-msybX0069 and cstc2016 shmszx130009).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ye Xu.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Ye Xu, email: yexu@cqmu.edu.cn., address: Department of Radiology, Children’s Hospital of Chongqing Medical University, 136 Zhongshan Er Lu, Yuzhong District, Chongqing 400000, China.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

Written informed consent was waived by the institutional review board.

Ethical approval

Institutional review board approval was obtained. The institutional review board of Children’s Hospital of Chongqing Medical University approved the study (protocol number: 2019–87), and the written informed consent was waived for this retrospective analysis.

Study subjects or cohorts overlap

Some study subjects or cohorts have been previously reported in our previous study [1].

1. Ma W, Li XJ, Li W, Xiao L, Ji XJ, Xu Y (2021) MRI findings of central nervous system involvement in children with haemophagocytic lymphohistiocytosis: correlation with clinical biochemical tests. Clin Radiol 76(2):159.e9-159.e17.

Methodology

• retrospective

• case–control study

• performed at one institution

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 381 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, W., Zhou, L., Li, W. et al. Brain MRI imaging markers associated with death in children with central nervous system involvement of hemophagocytic lymphohistiocytosis. Eur Radiol 34, 873–884 (2024). https://doi.org/10.1007/s00330-023-10147-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10147-8

Keywords

Navigation